Navigation Links
PharmAthene to Webcast its Third Quarter Conference Call on November 13, 2007 at 4:30 P.M. Eastern Time
Date:11/6/2007

ANNAPOLIS, Md., Nov. 6 /PRNewswire-FirstCall/ -- PharmAthene (Amex: PIP), a biodefense company specializing in the development of medical countermeasures against biological and chemical threats, will webcast its third quarter 2007 financial results conference call on Tuesday, November 13, 2007 at 4:30 p.m. Eastern Time. David Wright, President and Chief Executive Officer and Christopher Camut, Vice President and Chief Financial Officer will review the Company's operations, business outlook and current financial results. A press release announcing the third quarter results will be issued at 4:00 p.m. E.T. on Tuesday, November 13, 2007, and be available on the Company's website.

Conference Call Information

To access the call, the dial-in number within the United States is 866-510-0676. The dial-in number for international callers is 617-597-5361. The participant passcode is 15368854.

Conference Call Replay

A replay of the conference call will be available for 30 days, beginning at approximately 6:30 p.m. E.T. November 13th, 2007 until approximately 11:59 p.m. E.T. on December 13, 2007. The dial-in number from within the United States is 888-286-8010. For international callers, the dial-in number is 617-801-6888. The participant passcode is 84931672.

Webcast

The conference call will be also be webcast live and is accessible from the company's website at http://www.pharmathene.com. A link to the webcast may be accessed on the home page or under the 'Investor Relations' section of the website. The replay of the call will be available via webcast for 30 days, or until December 13, 2007.

About PharmAthene, Inc.

PharmAthene is a biodefense company formed in 2001 to meet the critical needs of the United States by developing biodefense products. PharmAthene is dedicated to the rapid development of important and novel biotherapeutics to address biological pathogens and chemicals that may be used as weapons of bioterror. PharmAthene's lead programs include Valortim(TM) and Protexia(R). For more information on PharmAthene, please visit http://www.pharmathene.com.


'/>"/>
SOURCE PharmAthene
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Exelixis Announces September 5 Webcast of Its 2007 IASLC Investor and Analyst Briefing
2. Gen-Probe Announces Webcast of Third Quarter 2007 Earnings Conference Call
3. Biopure Announces 2007 Third Quarter Financial Results
4. The Quigley Corporation Reports Third Quarter Results, Increases Investment in Pharmaceutical R&D for Diabetic Neuropathy
5. Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
6. QIAGEN N.V. (Nasdaq: QGEN) Invites You to Join Its Third Quarter 2007 Earnings Conference Call on the Web
7. Pharmacopeia Announces Third Quarter 2007 Financial Results
8. Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
9. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
10. Spherix Reports Second Quarter Earnings
11. Tapestry Reports Second Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... MELBOURNE, Australia , Feb. 21, 2017  IBM (NYSE: ... IBM Watson,s ability to detect abnormalities of the eye,s retina. ... trained a research version of Watson to recognize abnormalities in ... insights and speed in their early identification of patients who ... glaucoma, a leading cause of blindness in the developed world. ...
(Date:2/21/2017)... , Feb. 21, 2017 Medical Oxygen ... report: http://www.reportlinker.com/p04711311-summary/view-report.html Medical oxygen concentrators ... other respiratory diseases. Patients having low level of ... oxygen concentrators. Oxygen concentrators are to be used ... the counter. Medical oxygen concentrators work either on ...
(Date:2/21/2017)... , Feb. 21, 2017   BeyondSpring Pharmaceuticals ... the development of innovative immuno-oncology cancer therapies, today ... data from its Phase 2 trial of BeyondSpring,s ... treatment of non-small cell lung cancer (NSCLC) with ... this year,s ASCO-SITC Clinical Immuno-Oncology Symposium in ...
Breaking Medicine Technology:
(Date:2/22/2017)... ... February 22, 2017 , ... Alto-Shaam is pleased to ... Multi-Cook Oven offers up to four ovens in one. Control temperature, fan speed ... unmatched evenness in cooking. Alto-Shaam has partnered with Appliance Innovation to introduce this ...
(Date:2/22/2017)... FRANCISCO BAY AREA - NORTHERN CALIFORNIA (PRWEB) , ... ... ... (PMF) aims to expand the pipeline and the number of African American/Black ... that encourages medical students and residents to pursue their careers as physicians in ...
(Date:2/21/2017)... ... February 21, 2017 , ... Robins & Morton ... Durant, Oklahoma, on Feb. 21. , The celebration began with a ribbon cutting ... employees, the construction team and tribal leadership. , Choctaw Nation Durant Regional ...
(Date:2/21/2017)... CA (PRWEB) , ... February 21, 2017 , ... ... announce that Marc Philpart, senior director at PolicyLink, will be the keynote speaker ... about the Boys and Men of Color Framework, which develops comprehensive strategies to ...
(Date:2/21/2017)... ... 21, 2017 , ... As recently as 2015, rhinoplasty was one of the ... Plastic Surgeons. Some patients want to make a change in the appearance of their ... breathing ability. The team at usrhinoplasty.org is expanding its article database to ...
Breaking Medicine News(10 mins):